`
`UNITED STATES
`
`Page 1 of 2
`P.O. Box 1450
`
`Alexandtla,Viaauspto-gov
`
`ELECTRONIC ACKNOWLEDGEMENT RECEIPT
`
`
`
`APPLICATION #
`17/658,078
`
`RECEIPT DATE / TIME
`09/21/2023 07:18:00 PM ET
`
`ATTORNEY DOCKET #
`HRAKOO1.013D1
`
`Title of Invention
`
`FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES
`
`Application Information
`
`APPLICATION TYPE
`
`Utility - Nonprovisional Application
`under 35 USC 111(a)
`
`PATENT # -
`
`CONFIRMATION # 9207
`
`FILED BY Tayler Amerine
`
`PATENT CENTER # 62845187
`
`FILING DATE
`
`04/05/2022
`
`CUSTOMER # 20995
`
`CORRESPONDENEE
`
`-
`
`Documents
`
`FIRST NAMED Kwok Yin Tsang
`INVENTOR
`
`AUTHORIZED BY Kimberly Miller
`
`TOTAL DOCUMENTS: 3
`
`DOCUMENT
`
`PAGES
`
`DESCRIPTION
`
`SIZE (KB)
`
`2023-09-21 IDS -
`HRAKOO1.013D1.pdf
`
`2023-09-21 IDS -
`HRAKOO1.013D1-
`TRAN.LET.pdf
`
`2023-09-21 IDS -
`HRAKOO1.013D1-IDS.pdf
`
`NPL_IN_HearingNotice. pdf
`
`(1-1)
`
`(2-2)
`
`2
`
`1
`
`1
`
`3
`
`-
`
`Transmittal Letter
`
`Information Disclosure
`Statement (IDS) Form (SB08)
`
`4? KB
`
`19 KB
`
`21 KB
`
`Non Patent Literature
`
`3116 KB
`
`
`
`Digest
`
`DOCUMENT
`
`MESSAGE DIGEST(SHA-512)
`
`Page 2 of 2
`
`2023-09-21 IDS -
`HRAKO01.013D1.pdf
`
`
`
`
`73D411720140B 7D0A52B 315DE53687BBD710E20AEEF5ECOB1
`
`
`
`
`
`
`9CEBB576A087BD5677D2BD96743F BD5AB5374DAACO9B447E
`
`AlF83115B451E 3790D78793CF 3FFF73
`
`
`
`2023-09-21 IDS -
`
`HRAKOO1.013D1-
`TRAN.LET.paf
`
`60F BFF CICAE 6F 437D355938F 974532551F 316B7F 5385B43970
`
`EA289A992DC1797C2A68321CF 91DB5250493C6A4520105D492
`
`A847CE 98B85E 723BA0C05200AB 94
`
`2023-09-21 IDS -
`HRAKO01.013D1-IDS .pdf
`
`TIBDCEA9YC50D1IDGEA26BF 0196B409F BF 274B4D02763064591
`
`S3BDBB5BE 536B60F 18334B 8B97CF80703AC52B5563BC827BC
`
`4D4C 4017F F018A3773208CE 758FC1E
`
`NPL_IN_HearingNotice.paf
`
`9E07229CC68F 15426EED74123198940912CFC92938DD30F 29C
`
`44446E BOODDA277561DB0CCD533EBF56011E 8FB/0E68410B3
`
`D7D4F11165AA89B572190EF 6621FD
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents, characterized
`by the applicant, and including page counts, where applicable. Itserves as evidence of receipt similar to a Post Card, as
`described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`if a new application is being filed and the application includes the necessary components for filing date (see 37 CFR 1.53(b)-(d)
`and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this Acknowledgement
`Receipt will establish the filing date of the application
`
`National Stage of an International Application under 35 U.S.C. 371
`if a timely submission to enter the national stage of an international application is compliant with the conditions of 35 U.S.C.
`371 and other applicable requirements a Form PCT/DO/E0/903indicating acceptance of the application as a national stage
`submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`if a new international application is being filed and the international application includes the necessary components for an
`international filing date (see PCT Article 11 and MPEP 1810), a Notification of the Internationa! Application Number and of the
`international Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning national security,
`and the date shown on this Acknowledgement Receiptwill establish the international filing date of the application.
`
`



